The thrombosis versus bleeding risk dilemma: practical considerations with oral factor Xa inhibition

Event: ESC CONGRESS 2014
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium - Experts on the Spot
Sponsored by Bristol-Myers Squibb and Pfizer Alliance
Date: 1 September 2014
Time: 15:45 - 16:15

1 presentations in this session

Everyday clinical challenges in non-valvular atrial fibrillation and venous thromboembolism: your questions answered.

Speaker: Professor S. Hohnloser (Frankfurt, DE)
Speaker: Professor J. Alexander (Durham, US)
Speaker: Professor G. Agnelli (Perugia, IT)
Thumbnail

3 speakers from this session

Professor Stefan H Hohnloser

Johann Wolfgang Goethe University, Frankfurt (Germany)
27 presentations
1 follower

Professor John Alexander

Duke University Medical Center, Durham (United States of America)
3 presentations
0 follower

Professor Giancarlo Agnelli

University of Perugia, Perugia (Italy)
12 presentations
0 follower

This platform is supported by

logo Novo Nordisk